Reata Pharmaceuticals announced the appointment of Rajiv Patni, M.D., as Executive Vice President, and Chief Research & Development Officer. Dr. Patni will report to Warren Huff, CEO, and will be responsible for overseeing the company’s research and development functions. Prior to joining Reata, Dr. Patni was Chief Medical Officer at Global Blood Therapeutics from 2020 to 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RETA: